A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
Condition:   Relapsed or Refractory Multiple Myeloma Interventions:   Drug: Cevostamab;   Drug: Elranatamab;   Drug: Tocilizumab Sponsor:   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials

LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients
Conditions:   COVID-19;   Hospitalized COVID-19 Patients Interventions:   Drug: Lopinavir / Ritonavir;   Drug: Remdesivir (RDV);   Drug: Tocilizumab;   Other: Corticosteroid Therapy-enhanced Standard Care (CTSC) Sponsors:   Lebanese University;   Hospital Saydet Zgharta University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials